Identification of the Cutaneous Microbiota in Patients With Cutaneous Infection (MICROBIOTA)
1 other identifier
observational
100
1 country
1
Brief Summary
Identify the cutaneous microbiota on a cutaneous lesion (cellulite, wound, rash, etc.) on a swab, biopsies or abscess puncture and on "healthy" skin on a skin swab performed for cutaneous mapping to search for staphylococcal deposits.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 7, 2019
CompletedFirst Posted
Study publicly available on registry
June 13, 2019
CompletedStudy Start
First participant enrolled
July 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2022
CompletedJune 13, 2019
June 1, 2019
3 years
June 7, 2019
June 12, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Distribution of microorganisms found according to patient characteristics
Diagnosis by culture with identification by "Maldi tof" on cutaneous samples Molecular diagnosis with specific PCR identification of pathogens: Staphylococcus aureus, Streptococcus A, 16S rRNA and sequencing,
36 moths
Study Arms (1)
Person with a skin infection
For each person included in the study, skin sampling performed as part of the medical management of skin infections will be performed, associated with the contralateral healthy skin sampling.
Interventions
For each person included in the study, skin sampling performed as part of the medical management of skin infections will be performed, associated with the contralateral healthy skin sampling.
Eligibility Criteria
Any patient present meeting the inclusion criteria of the study will be offered to participate in the study.
You may qualify if:
- Patient with skin infections at admission
- Patient requiring skin mapping
- Person informed of the study and having expressed no opposition to participate in the study.
- Affiliate or beneficiary of a social security
You may not qualify if:
- Subject not agreeing to participate
- Vulnerable person: pregnant, parturient or nursing woman, person under guardianship or curatorship, or deprived of liberty by a judicial or administrative decision.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de maladies Infectieuses
Marseille, Cedex 5, 13354, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jean-Olivier ARNAUD
AP HM
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 36 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 7, 2019
First Posted
June 13, 2019
Study Start
July 1, 2019
Primary Completion
July 1, 2022
Study Completion
July 1, 2022
Last Updated
June 13, 2019
Record last verified: 2019-06